Table 2.
Cox regression analyses of prognostic factors affecting T1a glottic cancer patient survival in the training cohort.
| Overall survival | Cancer-specific survival | |||||||
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| Variable | HR(95%CI) | P | HR(95%CI) | P | HR(95%CI) | P | HR(95%CI) | P |
| Age, years | ||||||||
| <65 | Reference | Reference | Reference | |||||
| ≥65 | 1.67 (1.23–2.28) | .001 | 1.73 (1.27–2.37) | .001 | 1.00 (0.66–1.51) | 1 | ||
| Sex | ||||||||
| Female | Reference | Reference | ||||||
| Male | 0.89 (0.58–1.38) | .60 | 1.30 (0.63–2.68) | .48 | ||||
| Race | ||||||||
| Black | Reference | Reference | Reference | |||||
| White | 0.75 (0.49–1.17) | .20 | 0.83 (0.53–1.29) | .40 | 0.86 (0.44–1.65) | .64 | ||
| Other (American Indian/AK Native, Asian/Pacific Islander) | 0.21 (0.05–0.91) | .04 | 0.27 (0.06–1.16) | .08 | 0.24 (0.03–1.90) | .18 | ||
| Marital status | ||||||||
| Unmarried | Reference | Reference | Reference | |||||
| Married | 0.62 (0.47–0.83) | .001 | 0.65 (0.49–0.87) | .003 | 0.68 (0.45–1.02) | .06 | ||
| Grade | ||||||||
| Grade I&II | Reference | Reference | Reference | |||||
| Grade III&IV | 1.25 (0.80–1.94) | .33 | 2.15 (1.27–3.63) | .004 | 2.07 (1.22–3.51) | .007 | ||
| Stage (AJCC, 7th edition, 2010) | ||||||||
| I&II | Reference | Reference | Reference | Reference | ||||
| III&IV | 5.19 (2.29–11.74) | <.001 | 3.47 (1.48–8.15) | .004 | 8.53 (3.45–21.12) | <.001 | 6.09 (2.31–16.09) | <.001 |
| N | ||||||||
| N0 | Reference | Reference | Reference | Reference | ||||
| N1&N2 | 5.19 (2.29–11.74) | <.001 | NA∗ | 8.53 (3.45–21.12) | <.001 | NA∗ | ||
| M | ||||||||
| M0 | NA† | NA† | ||||||
| Primary site surgery | ||||||||
| No | Reference | Reference | Reference | Reference | ||||
| Yes | 0.68 (0.51–0.90) | .007 | 0.77 (0.57–1.05) | .10 | 0.61 (0.41–0.92) | .02 | 0.61 (0.41–0.93) | .02 |
| Radiation | ||||||||
| No/Unknown | Reference | Reference | Reference | |||||
| Yes | 1.62 (1.14–2.30) | .007 | 1.31 (0.90–1.90) | .16 | 1.33 (0.83–2.15) | .24 | ||
| Chemotherapy | ||||||||
| No/Unknown | Reference | Reference | Reference | Reference | ||||
| Yes | 3.55 (1.75–7.22) | <.001 | 3.12 (1.49–6.56) | .003 | 5.51 (2.40–12.61) | <.001 | 3.35 (1.37–8.21) | .008 |
| Year of diagnosis | ||||||||
| 2010–2012 | Reference | Reference | ||||||
| 2013–2015 | 0.79 (0.56–1.13) | .20 | 0.96 (0.59–1.54) | .85 | ||||